PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects
László Szidonya, Tara Barwick, Amarnath Challapalli, Mitesh Naik, Amy Eccles, Dennis Barbon, Nadine Mallak
Abstract
Prostate-specific membrane antigen (PSMA) radioligand therapy is an evolving treatment modality for patients with metastatic prostate cancer, offering improved survival and quality of life through a targeted and personalized theranostic approach.
Topics & Concepts
MedicineProstate cancerGlutamate carboxypeptidase IIRadioligandQuality of life (healthcare)Modality (human–computer interaction)OncologyProstateTreatment modalityCancerInternal medicineReceptorArtificial intelligenceNursingComputer scienceProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment